Overview
- AbbVie and Genentech, which joined Monday, become the 10th and 11th companies to sell through the White House’s TrumpRx portal.
- Humira is listed at $950 for uninsured patients, an 86% cut from list prices that can top $6,900, and Genentech’s Xofluza is about $50 instead of $168.
- The portal now features discounted cash prices for about 61 medications, up from roughly 40 at the February launch, with Amgen adding Enbrel and Otezla.
- The discounts apply only to people paying the full price out of pocket, so many insured patients may still owe less through their plan copays than the site’s cash price.
- The administration is using most‑favored‑nation agreements that peg U.S. cash prices to those in other countries, and officials say they want to extend these deals to public programs.